Cytek Biosciences, Inc.
Nasdaq · Technology · Laboratory Analytical Instruments · Fremont, CA
CTKB chart
What traders are saying about $CTKB
Latest postsCytek Biosciences, Inc. news
- Stephens & Co. maintains Cytek Biosciences at Overweight, raises price target to $7 from $6
TradingView ·
- Stephens raises Cytek Biosciences stock price target on margin gains
Investing.com ·
- Cytek Biosciences, Inc. (CTKB) Seasonal returns chart
Yahoo Finance UK ·
- Cytek Biosciences, Inc. (NASDAQ:CTKB) Analysts Are Pretty Bullish On The Stock After Recent Results
Simply Wall St ·
- Cytek Biosciences Stock Price Forecast. Should You Buy CTKB?
StockInvest.us ·
- Cytek Biosciences, Inc. (CTKB) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Cytek Biosciences opens new innovation center in Bellevue
scanx.trade ·
- Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year
Yahoo Finance ·
- Cytek Biosciences Raises FY26 Sales Guidance to $207M-$212M
scanx.trade ·
- Cytek Biosciences to showcase spectral cytometry at ESCCA and ICCS
scanx.trade ·
- Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript
fool.com ·
- Can Cytek Biosciences (NASDAQ:CTKB) Close a USD 6.1 Million Loss Despite 59% Gross Margin?
kalkine.ca ·
Cytek Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $201.5M | $200.5M | $193.0M | $164.0M |
| Net income | -$66.5M | -$6.0M | -$12.1M | $2.5M |
| Diluted EPS | – | – | $-0.09 | $0.02 |
| Total assets (year end) | $461.5M | $499.5M | $494.5M | $519.5M |
| Cash and equivalents (year end) | $90.9M | $98.7M | $167.3M | $296.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Cytek Biosciences, Inc.
- Ticker
- CTKB (Nasdaq)
- Industry
- Laboratory Analytical Instruments
- Headquarters
- Fremont, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1831915
Frequently asked questions
What exchange is Cytek Biosciences, Inc. listed on?
Cytek Biosciences, Inc. trades on the Nasdaq under the ticker symbol CTKB.
What industry is Cytek Biosciences, Inc. in?
Cytek Biosciences, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.
Where is Cytek Biosciences, Inc. headquartered?
Cytek Biosciences, Inc.'s business address on file with the SEC is in Fremont, CA.
When does Cytek Biosciences, Inc.'s fiscal year end?
Cytek Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Cytek Biosciences, Inc. report?
Cytek Biosciences, Inc. reported $201.5M in revenue for calendar year 2025, according to its SEC filings.